Global healthcare deal value increased in October 2025: GlobalData
GlobalData reports higher M&A and venture investment activity in the healthcare sector in October 2025.
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
GlobalData Report
New GMP standards in India expose fault line between regulators and MSMEs: GlobalData
GlobalData report highlights MSME concerns over India’s revised GMP and bio-equivalence mandates, warning that rapid enforcement…
Bladder cancer market to reach $16 billion in 8MM in 2033, forecasts GlobalData
Therapeutic innovation, including antibody-drug conjugates, sustained-release systems, and gene therapies, is driving rapid growth…
T-cell engagers to drive immuno-oncology next growth wave: GlobalData
Bispecific T-cell engagers forecast to expand from 10% to 35% of the global immuno-oncology market by 2031 as immune checkpoint…
Renewables to account for over half of Brazil’s annual power generation in 2035, forecasts…
Government policies, market liberalisation, and project development expected to accelerate Brazil’s shift from hydropower…
Pharma sector sees drop in deal value amid october 2024 activity: GlobalData report
Major acquisitions and venture capital investments signal continued activity despite decline in overall deal value
APAC leads in asthma clinical trials between 2019-2023: GlobalData
China, India, and South Korea among the top three countries
Pharma industry reports 79 M&A deals in October 2022
The industry reported 102 Venture Capital (VC) deals worth $1.8 billion in October 2022, compared to the last 12-month average…
Pharma industry’s deal value decreases by 74.8 per cent in September 2022
Venture capital investments decreased by 45.8 per cent in September 2022, compared to September 2021
13 of top 20 biopharma companies by revenue report over 10 per cent YoY revenue growth from 2020 to…
The majority of the top 20 innovative biopharma companies reported an increase in their revenue in 2021, with an aggregate revenue…